Recombinant Klebsiella pneumoniae subsp. pneumoniae Elongation factor Ts (tsf)

What is the functional role of Elongation Factor Ts (EF-Ts) in Klebsiella pneumoniae protein synthesis?

EF-Ts from K. pneumoniae functions as a guanine nucleotide exchange factor for Elongation Factor Tu (EF-Tu), catalyzing the release of GDP from EF-Tu and enabling it to bind a new GTP molecule. This recycling mechanism is essential for maintaining the active EF-Tu·GTP form that delivers aminoacyl-tRNAs to the ribosome during protein synthesis . In K. pneumoniae, as in other bacteria, EF-Ts plays a critical role in maintaining translation efficiency, particularly during rapid growth phases when protein synthesis demands are high. Unlike earlier assumptions that EF-Ts simply facilitates nucleotide exchange, recent research has revealed that EF-Ts directly impacts ternary complex formation and stability, suggesting a more complex regulatory role in bacterial translation .

How does the structure of K. pneumoniae EF-Ts compare to other bacterial species?

K. pneumoniae EF-Ts shares structural similarities with other bacterial EF-Ts proteins, particularly within the Enterobacteriaceae family. While specific structural data for K. pneumoniae EF-Ts is still emerging, comparative sequence analysis with other characterized bacterial EF-Ts proteins (such as those from E. coli and P. aeruginosa) indicates conservation of four key domains: the N-terminal domain (residues 1-54), core domain (residues 55-179), dimerization domain (residues 180-228), and C-terminal domain (residues 264-282) .

The dimerization domain contains four anti-parallel α-helices that facilitate the primary interaction between EF-Tu and EF-Ts to form their functional complex . Sequence homology analysis suggests K. pneumoniae EF-Ts shares approximately 85-90% identity with E. coli EF-Ts and approximately 55-60% identity with P. aeruginosa EF-Ts, with higher conservation in functional domains than in linker regions .

What protocols exist for cloning the tsf gene from Klebsiella pneumoniae?

The following protocol has been optimized for cloning the tsf gene encoding EF-Ts from K. pneumoniae:

• Genomic DNA extraction: Use standard bacterial genomic DNA isolation kits optimized for Gram-negative bacteria with adaptations for K. pneumoniae's capsule.

• Cloning vector selection: For optimal expression, pET-based vectors (pET101/D-TOPO or pET28a) have demonstrated high success rates for bacterial elongation factors .

• Transformation conditions: Transform into E. coli DH5α for plasmid propagation and sequence verification before transferring to an expression strain.

The major challenge in cloning K. pneumoniae genes is DNA purity due to its exopolysaccharide capsule. Incorporating additional purification steps or using specialized DNA extraction kits designed for capsulated bacteria significantly improves cloning success .

What are the optimal conditions for expressing recombinant K. pneumoniae EF-Ts in E. coli?

Optimal expression of recombinant K. pneumoniae EF-Ts in E. coli requires careful optimization of multiple parameters:

Expression System:

• Host strain: E. coli BL21(DE3)pLysS or Rosetta 2(DE3) for enhanced expression of proteins with rare codons

• Vector: pET-based vectors with T7 promoter

• Tags: C-terminal His6-tag for purification without compromising activity

Expression Conditions:

Lower induction temperatures (15-18°C) have been demonstrated to significantly increase the solubility of recombinant bacterial elongation factors while reducing inclusion body formation . Previous studies with recombinant EF-Ts from P. aeruginosa suggest that similar conditions should work effectively for K. pneumoniae EF-Ts, with reported yields of 15-20 mg/L of culture .

What purification strategy yields the highest purity and activity for recombinant K. pneumoniae EF-Ts?

A multi-step purification approach yields recombinant K. pneumoniae EF-Ts with >95% purity while maintaining functional activity:

• Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin

  • Buffer composition: 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10 mM imidazole

  • Elution: 250-300 mM imidazole gradient

  • Expected purity: 75-85%

• Intermediate purification: Ion exchange chromatography (IEX)

  • Q-Sepharose column (anion exchange)

  • Buffer: 50 mM Tris-HCl pH 7.5, 50 mM NaCl

  • Elution: 50-500 mM NaCl gradient

  • Expected purity: 85-90%

• Polishing step: Size exclusion chromatography (SEC)

  • Superdex 75 or 200 column

  • Buffer: 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2

  • Expected final purity: >95%

Critical considerations include:

• Maintain 5-10% glycerol in all buffers to enhance protein stability

• Include 1 mM DTT to prevent oxidation of cysteine residues

• Add 5 mM MgCl2 to final buffers to maintain structural integrity

The purified EF-Ts should be stored at -80°C in storage buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, 10% glycerol, 1 mM DTT) at a concentration of 1-2 mg/mL .

A potential complication is the co-purification of E. coli EF-Tu when K. pneumoniae EF-Ts is overexpressed in E. coli, as EF-Ts can bind to the host's EF-Tu. This can be addressed by introducing an additional ion exchange chromatography step or performing subtractive IMAC if the contaminant lacks a His-tag .

How can the nucleotide exchange activity of recombinant K. pneumoniae EF-Ts be quantitatively measured?

The nucleotide exchange activity of recombinant K. pneumoniae EF-Ts can be measured using multiple complementary approaches:

Method 1: Nitrocellulose filter binding assay

• Preincubate EF-Tu (1-5 μM) with [³H]GDP (1-2 μM) in buffer containing 50 mM Tris-HCl pH 7.5, 50 mM NH4Cl, 10 mM MgCl2, and 1 mM DTT

• Add varying concentrations of recombinant EF-Ts (0-10 μM)

• Add excess unlabeled GDP (100-200 μM)

• Filter aliquots through nitrocellulose at different time points

• Quantify remaining [³H]GDP bound to EF-Tu by scintillation counting

Method 2: Fluorescence-based real-time assay

• Use mant-GDP (fluorescent GDP analog) bound to EF-Tu

• Monitor fluorescence decrease upon displacement by unlabeled GDP catalyzed by EF-Ts

• Conditions: excitation 355 nm, emission 440 nm

• Calculate rate constants from time-course measurements

Based on studies with other bacterial EF-Ts proteins, expected kinetic parameters for K. pneumoniae EF-Ts would be:

Recombinant K. pneumoniae EF-Ts typically stimulates the GDP exchange rate of EF-Tu by 10-20 fold, which is a critical benchmark for confirming functional activity of the purified protein .

What methods can be used to study the interaction between K. pneumoniae EF-Ts and EF-Tu?

Several complementary techniques can characterize the EF-Ts:EF-Tu interaction with varying degrees of detail:

Gel Filtration Analysis

• Load preincubated EF-Tu:EF-Ts mixtures on a calibrated Superdex 200 column

• Use buffer containing 50 mM Tris-HCl pH 7.5, 100 mM KCl, 10 mM MgCl2

• Analyze fractions by SDS-PAGE to identify complex formation

• Expected result: Co-elution of both proteins at a position corresponding to ~80-85 kDa (complex)

Isothermal Titration Calorimetry (ITC)

• Titrate EF-Ts (200-300 μM) into EF-Tu (20-30 μM)

• Measure heat changes to determine:

  • Binding stoichiometry (expected 1:1)

  • Dissociation constant (KD typically 10-50 nM)

  • Thermodynamic parameters (ΔH, ΔS, ΔG)

Surface Plasmon Resonance (SPR)

• Immobilize His-tagged EF-Tu on a Ni-NTA sensor chip

• Flow varying concentrations of EF-Ts over the surface

• Analyze association and dissociation kinetics

• Expected kon: 1-5 × 10⁶ M⁻¹s⁻¹; koff: 0.05-0.1 s⁻¹

Pull-down Assays

• Immobilize His-tagged EF-Tu on Ni-NTA resin

• Incubate with EF-Ts

• Wash and elute bound complexes

• Analyze by SDS-PAGE and Western blotting

• Controls should include nucleotide dependence tests (GDP vs. GTP vs. no nucleotide)

The interaction between K. pneumoniae EF-Ts and EF-Tu is expected to be strong but transient, with a 1:1 stoichiometry and KD in the nanomolar range (10-50 nM). This interaction is typically nucleotide-dependent, with stronger binding observed in the presence of GDP compared to GTP .

How can recombinant K. pneumoniae EF-Ts be used to study ternary complex formation and stability?

Recombinant K. pneumoniae EF-Ts can provide significant insights into ternary complex (EF-Tu·GTP·aa-tRNA) formation and stability through the following methodologies:

Ternary Complex Formation Assay:

• Prepare a reaction containing EF-Tu (1-5 μM), GTP (0.5 mM), and varying concentrations of EF-Ts (0-10 μM)

• Add [³H]aminoacyl-tRNA (1-2 μM)

• Incubate for 15 minutes at 4°C

• Add RNase A (0.025 mg/mL) and incubate for 20 seconds

• Stop reaction with 5% trichloroacetic acid (TCA)

• Filter through nitrocellulose and quantify retained radioactivity

This assay measures the ability of EF-Tu to protect aminoacyl-tRNA from RNase degradation, which only occurs when a stable ternary complex forms.

Real-time Fluorescence Assay:

• Use fluorescently labeled tRNA or mant-GTP

• Monitor ternary complex formation kinetics in real-time

• Compare rates with and without EF-Ts

Recent research has revealed that EF-Ts not only facilitates nucleotide exchange but directly impacts both the formation and disassociation rates of ternary complexes . This unexpected finding suggests EF-Ts plays a regulatory role in controlling ternary complex stability and availability.

Expected observations with K. pneumoniae EF-Ts:

• Accelerated ternary complex formation (2-4 fold faster rates)

• Increased ternary complex dissociation rates

• Attenuation of EF-Tu affinity for GTP in the presence of EF-Ts

• Destabilization of ternary complex with non-hydrolyzable GTP analogs

These effects appear to be mediated by EF-Ts influencing a rate-determining conformational change in EF-Tu that controls both ternary complex formation and decay .

How can structural analysis of K. pneumoniae EF-Ts inform antibiotic development strategies?

Structural characterization of K. pneumoniae EF-Ts provides valuable insights for antibiotic development through several approaches:

X-ray Crystallography

• Co-crystallize EF-Ts with EF-Tu in different nucleotide states

• Identify unique structural features and interaction interfaces

• Focus on regions that differ from human mitochondrial EF-Ts (TSFM)

Molecular Dynamics Simulations

• Model EF-Ts in complex with EF-Tu and small molecules

• Identify potential binding pockets and allosteric sites

• Simulate the effect of binding on protein dynamics

Fragment-Based Drug Discovery

• Screen fragment libraries against purified EF-Ts

• Use NMR or X-ray crystallography to identify binding sites

• Develop higher-affinity compounds from initial fragments

The EF-Tu:EF-Ts interface represents a promising target for antimicrobial development for several reasons:

• The protein translation machinery is a validated antibiotic target

• EF-Ts is essential for bacterial growth, particularly under stress conditions

• The EF-Tu:EF-Ts interaction surface contains bacterial-specific features

• Inhibition of this interaction would impair multiple steps in protein synthesis

Structural analysis reveals that the dimerization domain of EF-Ts (four anti-parallel α-helices) provides the primary contact surface with EF-Tu . Additionally, the C-terminal domain interacts with the GTPase domain of EF-Tu. Compounds targeting either of these interfaces could potentially disrupt EF-Tu:EF-Ts interaction and inhibit bacterial growth.

Comparative analysis with other bacterial pathogens reveals that K. pneumoniae EF-Ts shares significant structural similarity with other Enterobacteriaceae, suggesting that inhibitors might have broad-spectrum activity against related pathogens .

What role does EF-Ts play in the pathogenesis and antibiotic resistance of K. pneumoniae infections?

The role of EF-Ts in K. pneumoniae pathogenesis and antibiotic resistance is multifaceted and emerging as an important area of research:

Stress Adaptation

• EF-Ts becomes especially critical during stress conditions when protein synthesis must adapt

• Under antibiotic stress, efficient recycling of EF-Tu may contribute to survival mechanisms

• In genome-wide network analysis, tsf appears connected to metabolic pathways essential for in-host survival

Moonlighting Functions

• Similar to findings with other bacterial species, EF-Ts may have non-canonical roles beyond translation

• In related bacteria, elongation factors have been shown to:

  • Contribute to membrane integrity

  • Participate in biofilm formation

  • Interact with host proteins during infection

  • Modulate stress responses

Antibiotic Resistance Connections

• Alterations in translation machinery components are increasingly linked to resistance mechanisms

• Upregulation of tsf has been observed in some multidrug-resistant clinical isolates

• Metabolic network analysis identifies the translation machinery as a hub connecting resistance pathways

Virulence Factor Expression

• Efficient translation is required for proper expression of virulence factors

• K. pneumoniae virulence depends on capsule production, which requires high translational capacity

• The EF-Tu:EF-Ts system may be particularly important during rapid growth phases in infection

A network-based metabolism-centered screening approach identified components of the translation machinery, including elongation factors, as potential targets for addressing antibiotic resistance in K. pneumoniae . While direct evidence specifically linking EF-Ts to resistance mechanisms is still emerging, its essential role in protein synthesis makes it relevant to any adaptation requiring altered protein expression profiles, including antibiotic resistance.

What are the common pitfalls in expressing and purifying functional recombinant K. pneumoniae EF-Ts?

Researchers frequently encounter several challenges when working with recombinant K. pneumoniae EF-Ts:

Co-purification with Host EF-Tu

• Problem: EF-Ts from K. pneumoniae can bind to E. coli EF-Tu when expressed in E. coli, resulting in co-purification

• Solution:

  • Include additional ion exchange chromatography steps

  • Use high-salt washes (300-500 mM NaCl) during initial IMAC purification

  • Consider dual-tagged constructs for tandem purification

Aggregation and Inclusion Body Formation

• Problem: EF-Ts can form inclusion bodies, particularly at higher expression temperatures

• Solution:

  • Lower induction temperature to 15-18°C

  • Express with solubility-enhancing fusion tags (MBP, SUMO)

  • Add 5-10% glycerol to lysis and purification buffers

  • Include 1 mM DTT to prevent disulfide-mediated aggregation

Activity Loss During Purification

• Problem: EF-Ts activity can decrease significantly during purification

• Solution:

  • Minimize purification time (complete within 24-36 hours)

  • Include 5 mM MgCl₂ in all buffers

  • Verify activity after each purification step

  • Store at -80°C in small aliquots with 10% glycerol

Protein Instability

• Problem: Purified EF-Ts may gradually lose activity during storage

• Solution:

  • Add carrier protein (BSA) for dilute solutions

  • Avoid repeated freeze-thaw cycles

  • Store at concentrations above 1 mg/mL

  • Consider lyophilization in suitable buffer formulations

Inconsistent Activity Measurements

• Problem: Activity assays can show high variability

• Solution:

  • Standardize nucleotide and magnesium concentrations

  • Control temperature precisely during assays

  • Include internal controls with each assay

  • Use multiple complementary activity assays

One underappreciated aspect is the potential requirement for post-translational modifications that may be present in native K. pneumoniae EF-Ts but absent in recombinant versions expressed in E. coli. This might explain cases where recombinant protein shows lower activity than expected .

How can the interaction between recombinant K. pneumoniae EF-Ts and K. pneumoniae ribosomes be studied in vitro?

Investigating the interaction between recombinant K. pneumoniae EF-Ts and K. pneumoniae ribosomes requires specialized techniques:

Ribosome Binding Assays

• Prepare purified K. pneumoniae ribosomes (or use B. subtilis ribosomes as substitutes)

• Set up reactions containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 0.1 mM spermine

  • 40 mM KCl

  • 4 mM MgCl₂

  • 1 mM DTT

  • 0.3 mM GTP

  • 0.15 mg/mL poly(U) mRNA

  • 4-5 μM K. pneumoniae EF-Tu

  • Varying concentrations of EF-Ts (0-10 μM)

  • 0.5 μM ribosomes

  • 0.6 μM [³H]Phe-tRNA^Phe

• Filter through nitrocellulose and quantify radioactivity retained

In vitro Translation System

• Develop a complete K. pneumoniae-derived translation system containing:

  • Purified ribosomes

  • All translation factors (including EF-Tu, EF-G)

  • tRNAs and aminoacyl-tRNA synthetases

  • Test the effect of adding or removing EF-Ts on translation efficiency

  • Measure incorporation of radiolabeled amino acids into polypeptides

Ribosome Profiling with Recombinant Components

• Prepare translation initiation complexes with mRNA, 70S ribosomes, and initiator tRNA

• Add purified elongation components including EF-Tu, EF-Ts, and aminoacyl-tRNAs

• Analyze ribosome positioning and translation kinetics

• Compare results with and without EF-Ts

Cryo-electron Microscopy

• Capture the interaction of EF-Tu:EF-Ts with ribosomes at different functional states

• Prepare samples with non-hydrolyzable GTP analogs to trap specific conformational states

• Generate structural models of the delivery of aminoacyl-tRNA to the ribosome

A key insight from recent research is that EF-Ts influences not just the nucleotide exchange on EF-Tu but may also indirectly affect the interaction of the ternary complex with the ribosome by modulating EF-Tu conformation . The presence of EF-Ts has been shown to influence the rate of conformational change of EF-Tu on the ribosome, particularly when aa-tRNA binds to a cognate versus a near-cognate codon .

How can recombinant K. pneumoniae EF-Ts be used in developing novel antimicrobial strategies against multidrug-resistant strains?

Recombinant K. pneumoniae EF-Ts offers several promising approaches for developing novel antimicrobials:

High-Throughput Screening Platforms

• Develop fluorescence-based assays to screen compound libraries

• Design assays measuring:

  • EF-Ts:EF-Tu interaction disruption

  • Inhibition of nucleotide exchange activity

  • Interference with ternary complex formation

• Screen natural product libraries for novel scaffold identification

Structure-Guided Drug Design

• Use crystal structures of K. pneumoniae EF-Ts alone and in complex with EF-Tu

• Identify unique pockets and interaction surfaces

• Design small molecules targeting:

  • The dimerization domain-EF-Tu interface

  • Allosteric sites that alter EF-Ts conformation

  • The nucleotide exchange catalytic mechanism

Peptide-Based Inhibitors

• Develop peptide mimetics based on interface residues

• Create stabilized alpha-helical peptides corresponding to the dimerization domain

• Engineer cell-penetrating peptides that can reach intracellular targets

Antisense Strategies

• Target tsf mRNA using antisense oligonucleotides

• Develop peptide nucleic acids (PNAs) with enhanced bacterial penetration

• Combine with outer membrane permeabilizers for effective delivery

CRISPR-Cas System Delivery

• Target the tsf gene using phage-delivered CRISPR-Cas systems

• Engineer sequence-specific nucleases that can discriminate between pathogenic and commensal bacteria

Recent research on K. pneumoniae metabolism has identified several connections between translation machinery and antibiotic resistance pathways . A network-based metabolic approach revealed that targeting components like EF-Ts could potentially disrupt multiple resistance mechanisms simultaneously, offering advantages over conventional single-target approaches.

The development of genetic manipulation protocols for K. pneumoniae provides tools to validate EF-Ts as a target through knockout/knockdown studies and complementation experiments. These genetic approaches can help establish the essentiality of EF-Ts under different growth conditions and infection scenarios.

What are the implications of post-translational modifications on K. pneumoniae EF-Ts function in stress conditions?

Post-translational modifications (PTMs) of K. pneumoniae EF-Ts may play crucial regulatory roles under stress conditions, with significant implications for pathogenesis and antimicrobial resistance:

Potential PTMs of Bacterial EF-Ts

• Phosphorylation: Modulates activity and protein-protein interactions

• Methylation: Affects structural stability and binding properties

• Acetylation: Regulates function and localization

• Oxidation: Occurs during oxidative stress, potentially altering function

Stress-Responsive Regulation

• Oxidative stress: Cysteine residues may undergo reversible oxidation

• Nutrient limitation: Phosphorylation states may change to conserve energy

• Antibiotic exposure: Pattern of PTMs may shift as part of adaptive response

• Temperature stress: Modifications may stabilize protein structure

Research Methodologies for PTM Analysis

• Mass spectrometry-based proteomics:

  • Phosphoproteomics to identify phosphorylation sites

  • Redox proteomics to detect oxidative modifications

• Site-directed mutagenesis:

  • Generate mutants mimicking or preventing specific PTMs

  • Compare activity and interaction properties

• In vitro modification:

  • Treat purified protein with kinases, acetylases, etc.

  • Measure functional changes after modification

4. Moonlighting Functions Under Stress
Recent research has revealed that bacterial elongation factors often exhibit moonlighting functions under stress conditions . For K. pneumoniae EF-Ts, these might include:

• Chaperone-like activity under heat shock

• RNA-binding functions during cold stress

• Membrane association during cell envelope stress

• Interactions with host proteins during infection

In related bacterial species, EF-Tu has been shown to relocate to the cell surface under stress conditions, where it can interact with host molecules like plasminogen . Similar behavior might be expected for K. pneumoniae EF-Ts, potentially regulated by specific PTMs that facilitate membrane association or surface exposure.

Understanding these PTM-dependent functions could reveal novel aspects of K. pneumoniae stress adaptation and identify new intervention strategies targeting stress response pathways.

How does K. pneumoniae EF-Ts differ from EF-Ts proteins in other clinically relevant bacterial pathogens?

K. pneumoniae EF-Ts exhibits both conserved features and unique characteristics when compared to EF-Ts from other pathogenic bacteria:

Sequence and Structural Comparison:

Functional Differences:

• Nucleotide Exchange Kinetics: K. pneumoniae EF-Ts catalyzes GDP/GTP exchange with efficiency similar to E. coli but different from P. aeruginosa (which shows ~2-fold higher rates)

• Thermal Stability: K. pneumoniae EF-Ts likely exhibits thermal stability properties characteristic of Enterobacteriaceae, distinct from more thermolabile species like M. pneumoniae

• EF-Tu Binding Specificity: While K. pneumoniae EF-Ts can interact with EF-Tu from related Enterobacteriaceae, it shows reduced affinity for EF-Tu from more distant species

• Surface Properties: Analysis of electrostatic surface potentials reveals pathogen-specific patterns of charged residues that could affect interaction networks

These differences provide important considerations for developing species-specific inhibitors. For example, compounds targeting the interaction interface between EF-Ts and EF-Tu could be designed to exploit the unique residues present in K. pneumoniae EF-Ts that differ from commensal bacteria.

The fact that bacterial EF-Ts proteins diverge significantly from human mitochondrial EF-Ts (TSFM, <25% identity) provides an opportunity for selective targeting of bacterial protein synthesis without affecting host translation machinery.

What insights do computational studies provide about targeting K. pneumoniae EF-Ts for antimicrobial development?

Computational approaches offer valuable insights for targeting K. pneumoniae EF-Ts:

Molecular Docking and Virtual Screening

• In silico screening of compound libraries against K. pneumoniae EF-Ts structural models identifies potential inhibitors

• Focused docking at the EF-Tu:EF-Ts interface reveals key binding pockets

• Virtual screening against multiple conformational states captures dynamics-dependent binding opportunities

• Fragment-based approaches identify chemical scaffolds with optimal binding properties

Molecular Dynamics Simulations

• Simulations reveal dynamic properties not captured in static structures

• Analysis of conformational flexibility identifies transiently exposed binding sites

• Water mapping identifies hydration patterns that can be exploited for ligand design

• Energy decomposition analysis pinpoints residues contributing most to binding energetics

Network-Based Systems Biology Approaches

• Network analysis of K. pneumoniae metabolism identifies EF-Ts as part of critical hub connecting multiple essential pathways

• Perturbation simulations predict system-wide effects of EF-Ts inhibition

• Flux balance analysis models predict how EF-Ts inhibition affects growth under different conditions

Structural Bioinformatics Findings

• Conservation analysis reveals functionally critical versus variable regions

• Binding site comparison across multiple pathogens identifies pathogen-specific pockets

• Identification of allosteric communication pathways suggests indirect inhibition strategies

• Analysis of coevolved residues pinpoints structurally and functionally linked positions

Recent computational studies using gene- and metabolite-centric approaches have mapped the metabolic network of K. pneumoniae MGH 78578, revealing potential targets including translation components . These studies emphasized the importance of targeting components that affect multiple metabolic pathways simultaneously, a criterion that translation factors like EF-Ts satisfy.

Computational models simulating bacterial growth within different host-mimicking media provide more realistic infection scenarios for predicting the effectiveness of EF-Ts inhibition . These simulations suggest that targeting translation machinery components may be particularly effective in resource-limited host environments where protein synthesis becomes a bottleneck for pathogen survival.

How might CRISPR-Cas techniques advance our understanding of K. pneumoniae EF-Ts function in vivo?

CRISPR-Cas technologies offer powerful approaches to investigate K. pneumoniae EF-Ts function:

Conditional Gene Knockdown Systems

• Implement CRISPRi systems to create tunable knockdown of tsf gene expression

• Design guide RNAs targeting different regions of the tsf promoter or coding sequence

• Use inducible dCas9-repressor constructs to control timing of knockdown

• Examine phenotypic consequences under various infection-relevant conditions

Gene Tagging for Localization Studies

• Employ CRISPR-mediated homology-directed repair to introduce fluorescent tags

• Create EF-Ts-GFP fusions at the native locus to maintain physiological expression

• Track subcellular localization during different growth phases and stress conditions

• Combine with super-resolution microscopy to resolve spatial organization

Base Editing for Structure-Function Analysis

• Use CRISPR base editors to introduce precise point mutations

• Target conserved residues in functional domains:

  • Dimerization domain interface residues

  • Core domain catalytic elements

  • N-terminal and C-terminal regulatory regions

• Assess effects on growth, stress resistance, and virulence

In vivo Interaction Networks

• Employ CRISPR-mediated tagging for proximity labeling approaches

• Introduce BioID or APEX2 fusions to identify proximal proteins in living cells

• Map the extended interaction network of EF-Ts under different conditions

• Discover potential moonlighting functions and stress-specific interactions

Genetic Interaction Mapping

• Create CRISPR-based genetic interaction screens

• Identify synthetic lethal or synthetic sick interactions with tsf

• Discover pathways functionally connected to translation elongation

• Map genetic suppressors that rescue tsf deficiency

Recent advances in genetic manipulation protocols for K. pneumoniae provide the foundational tools needed for these approaches . The development of specialized protocols addressing the challenges posed by K. pneumoniae's exopolysaccharide capsule has made previously difficult genetic manipulations more accessible .

These CRISPR-based approaches would help resolve several outstanding questions, including the essentiality of EF-Ts under different conditions, potential moonlighting functions, and the specific contribution of EF-Ts to virulence and antibiotic resistance in vivo.

What novel biochemical approaches could reveal unexpected functions of K. pneumoniae EF-Ts?

Several innovative biochemical techniques could uncover non-canonical functions of K. pneumoniae EF-Ts:

Interactome Profiling

• Pull-down coupled with mass spectrometry:

  • Use recombinant His-tagged EF-Ts as bait

  • Incubate with K. pneumoniae lysates under various stress conditions

  • Identify condition-specific interaction partners

  • Validate key interactions with co-immunoprecipitation

• Proximity-dependent biotin labeling:

  • Express EF-Ts-BioID fusion in K. pneumoniae

  • Map proximal proteins in living bacteria

  • Compare interactome under normal vs. stress conditions

RNA-Interaction Studies

• RNA immunoprecipitation (RIP):

  • Use antibodies against EF-Ts to precipitate associated RNAs

  • Sequence and identify bound RNAs

  • Map binding sites with CLIP-seq approaches

• In vitro RNA binding assays:

  • Test recombinant EF-Ts binding to different RNA species

  • Examine sequence or structural preferences

  • Investigate potential regulatory functions in RNA metabolism

Post-translational Modification Mapping

• Redox proteomics:

  • Characterize oxidative modifications under oxidative stress

  • Identify redox-sensitive cysteine residues

  • Determine impact on protein function

• Phosphoproteomics:

  • Map phosphorylation sites under different conditions

  • Identify kinases involved in EF-Ts regulation

  • Create phosphomimetic/phosphodeficient mutants to assess functional consequences

Membrane Interaction Studies

• Liposome binding assays:

  • Test recombinant EF-Ts binding to model membranes

  • Examine lipid composition preferences

  • Assess potential membrane-associated functions

• Surface plasmon resonance:

  • Quantify membrane interaction kinetics

  • Determine effects of nucleotides and EF-Tu on membrane binding

Host-Pathogen Interaction Analysis

• Bacterial surface display:

  • Test if EF-Ts can be displayed on bacterial surface like EF-Tu

  • Examine potential interactions with host proteins

• Binding to host extracellular matrix components:

  • Test recombinant EF-Ts binding to fibronectin, plasminogen, etc.

  • Determine if EF-Ts can activate plasminogen like EF-Tu in other bacteria

  • Assess potential roles in adherence and invasion

Recent studies have revealed that elongation factors in various bacteria exhibit unexpected moonlighting functions, including roles in virulence, stress response, and host interaction . For example, EF-Tu has been shown to moonlight on the surface of Staphylococcus aureus and Mycoplasma pneumoniae, where it can bind to host proteins . Similar non-canonical functions might exist for K. pneumoniae EF-Ts, particularly under stress conditions or during host interaction.